Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19

10 Jan 2023

Abstract excerpt

Evolution of SARS-CoV-2 in immunocompromised hosts may result in novel variants with changed properties. While escape from humoral immunity certainly contributes to intra-host evolution, escape from cellular immunity is poorly understood. Here, we report a case of long-term COVID-19 in an immunocompromised patient with non-Hodgkin's lymphoma who received treatment with rituximab and lacked neutralizing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36627290
DOI: 10.1038/s41467-022-34033-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19PMID 36627290Read ↗

SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19Semantic proximity Read ↗

Extensive Intra-host evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised hostSemantic proximity Read ↗

Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.Semantic proximity Read ↗

Molecular Characterization of Persistent SARS-CoV-2 Infections in Immunocompromised Patients.Semantic proximity Read ↗

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised PatientsSemantic proximity Read ↗

The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient – a case studySemantic proximity Read ↗

Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection.Semantic proximity Read ↗

SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesSemantic proximity Read ↗

Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.Semantic proximity Read ↗

Atypical COVID-19 dynamics in a patient with Mantle Cell Lymphoma Exposed to RituximabSemantic proximity Read ↗

SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopesSemantic proximity Read ↗

SARS-CoV-2 shedding, infectivity and evolution in an immunocompromised adult patientSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.